BRCA2 loss-of-function variants are present in 0.14%−0.22% of the general population30,55; therefore the incidence in pediatric AML is 4.57 times higher than the general population, which is concordant with the reported odds ratio from Stubbins et al53. Here, BRCA2 is linked to acute myeloid leukemia.